DALLAS, Sept. 23, 2009 (GLOBE NEWSWIRE) -- StockPreacher.com announces an investment report featuring biotechnology company Advanced Cell Technology Inc. (Pink Sheets:ACTC). The report includes financial and investment analysis, analyst consensus, and pertinent industry information you need to know to make an educated investment decision.
The investment report on Advanced Cell Technology Inc. (Pink Sheets:ACTC) should be of particular interest to other biotechnology companies: Geron Corp. (Nasdaq:GERN), StemCells Inc. (Nasdaq:STEM) and Aastrom Biosciences Inc. (Nasdaq:ASTM).
The full report is available at: http://www.stockpreacher.com/n/ACTC
Advanced Cell Technology Inc. (ACTC) is a biotechnology company engaged in the development and commercialization of human embryonic and adult stem-cell technology in the field of regenerative medicine. It primarily focuses on cellular reprogramming, reduced complexity program, and stem cell differentiation research programs. The Company develops adult stem cell-based products that are specifically targeted at therapies for heart and other cardiovascular diseases.
In the report, the analyst notes:
"The hemangioblast (HG) cell program, for which the Company is currently conducting preclinical research programs, investigates the possibility of using stem cells to treat cardiovascular disease, stroke and cancer. The Company has already published positive data in the journal NATURE Methods for its HG cellular program and expects to file the IND over the short term.
"In recent years, ACTC has announced the successful development of a novel technique to generate embryonic stem-cell lines without destroying embryos, a breakthrough in the ethical debate surrounding the industry. Since then, the Company has announced on multiple occasions the successful creation of human embryonic stem-cell lines without the destruction or disruption of the developmental potential of the embryos. In support of its research and applications ACTC owns or licenses more than 380 patents and patent applications."
To read the entire report visit: http://www.stockpreacher.com/n/ACTC
See what investors are saying about these stocks at: http://www.stockhideout.com/
StockPreacher.com is a small-cap research and investment commentary provider. StockPreacher.com strives to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the public information available on them. For more information on StockPreacher, please visit: http://www.stockpreacher.com
StockPreacher.com Disclosure
StockPreacher.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. StockPreacher.com is a Web site wholly-owned by BlueWave Advisors, LLC. Please read our report and visit our Web site, StockPreacher.com, for complete risks and disclosures.